• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EVOQUE TRICUSPID VALVE REPLACEMENT SYSTEM; PERCUTANEOUSLY DELIVERED PROSTHESES AND TRICUSPID VALVES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EVOQUE TRICUSPID VALVE REPLACEMENT SYSTEM; PERCUTANEOUSLY DELIVERED PROSTHESES AND TRICUSPID VALVES Back to Search Results
Model Number 9850TDSUS
Medical Device Problem Code Malposition of Device (2616)
Health Effect - Clinical Code Cardiac Perforation (2513)
Date of Event 10/03/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The manufacturer's investigation is ongoing and a follow-up report will be submitted when the investigation is complete.
 
Event or Problem Description
Edwards received notification of a transcatheter tricuspid valve replacement (ttvr) procedure involving the evoque system where the guidewire was sitting at the apex of the right ventricle (rv) when the perforation occurred.The perforation/pericardial effusion was caused by the wire.The initial guidewire placement was easy, uneventful and on posterior septal.Free wire at wire check and wire position was appropriate.No significant wire pressure observed during crossing, crossing was slow and controlled due to proximity of pacing lead.The delivery system (ds) crossing was slow and controlled and managed wire while crossing.The wire advanced more apically after crossing the valve with more of the stiff section exposed from the ds and there was possible tension at the ivc level.The wire was retracted, and anesthesia noted a drop in the patient's blood pressure.Echo was done and there was a large pericardial effusion observed.The ds was across the valve when the perforation occurred.There was no other indication on fluoro other than wire curl appearing deeper and deformation of the curl.There was no intentional push on the guidewire to obtain height and/or navigational maneuvers with excess force already on the guidewire.Ic did not feel like he had unusual wire pressure.As per medical opinion, the perceived root cause of the event was a combination of friable rv (per cardiothoracic surgeon) and not enough wire tension.Cardiopulmonary resuscitation (cpr) was performed and procedure was converted to open heart to repair the perforation and stabilize the patient.The patient's final outcome was reported to be awake, responsive and stable condition.
 
Additional Manufacturer Narrative
The following sections were updated/corrected/added: b4, g3, g6, h2, h6, and h11.Additional type of investigation codes that were unable to be added in h6: analysis of images.Labelling review.The complaint for delivery system and/or guidewire pushed into ventricular wall was confirmed with objective evidence.The device history record review was completed, and this device passed all manufacturing and sterilization inspections.No nonconformances related to the complaint event were identified.The available information indicates that wire management combined with challenging patient anatomy were the likely root causes of the rv injury.Since no manufacturing non-conformances were found and no labeling, training, or ifu deficiencies were identified, no preventative or corrective actions were required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVOQUE TRICUSPID VALVE REPLACEMENT SYSTEM
Common Device Name
PERCUTANEOUSLY DELIVERED PROSTHESES AND TRICUSPID VALVES
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
cassandra cook
1 edwards way
irvine, CA 92614
5743778277
MDR Report Key23359617
Report Number2015691-2025-08721
Device Sequence Number8965058
Product Code NPW
UDI-Device Identifier00690103217520
UDI-Public(01)00690103217520(17)260318(11)250318
Combination Product (Y/N)N
Initial Reporter StateIL
Initial Reporter CountryUS
PMA/510(K) Number
P230013
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/15/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date03/18/2026
Device Model Number9850TDSUS
Device Lot Number66360557
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/03/2025
Supplement Date Received by Manufacturer12/12/2025
Initial Report FDA Received Date10/22/2025
Supplement Report FDA Received Date12/15/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured03/18/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age82 YR
Patient SexFemale
Patient Weight73 KG
-
-